- Home
- CLGN vs GLST Comparison
CLGN vs GLST Comparison
Compare CLGN & GLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- GLST
- Stock Information
- Founded
- CLGN 2004
- GLST 2019
- Country
- CLGN Israel
- GLST United States
- Employees
- CLGN N/A
- GLST N/A
- Industry
- CLGN Industrial Specialties
- GLST Consumer Electronics/Appliances
- Sector
- CLGN Health Care
- GLST Industrials
- Exchange
- CLGN Nasdaq
- GLST Nasdaq
- Market Cap
- CLGN 46.2M
- GLST 48.0M
- IPO Year
- CLGN N/A
- GLST 2022
- Fundamental
- Price
- CLGN $3.47
- GLST $6.47
- Analyst Decision
- CLGN Strong Buy
- GLST
- Analyst Count
- CLGN 2
- GLST 0
- Target Price
- CLGN $12.50
- GLST N/A
- AVG Volume (30 Days)
- CLGN 5.1K
- GLST 17.3K
- Earning Date
- CLGN 04-03-2025
- GLST 01-01-0001
- Dividend Yield
- CLGN N/A
- GLST N/A
- EPS Growth
- CLGN N/A
- GLST N/A
- EPS
- CLGN N/A
- GLST N/A
- Revenue
- CLGN $650,000.00
- GLST N/A
- Revenue This Year
- CLGN N/A
- GLST N/A
- Revenue Next Year
- CLGN $692.59
- GLST N/A
- P/E Ratio
- CLGN N/A
- GLST N/A
- Revenue Growth
- CLGN N/A
- GLST N/A
- 52 Week Low
- CLGN $3.24
- GLST $6.04
- 52 Week High
- CLGN $6.75
- GLST $20.89
- Technical
- Relative Strength Index (RSI)
- CLGN 36.66
- GLST 35.16
- Support Level
- CLGN $3.52
- GLST $7.83
- Resistance Level
- CLGN $3.70
- GLST $20.89
- Average True Range (ATR)
- CLGN 0.16
- GLST 3.10
- MACD
- CLGN -0.02
- GLST -0.36
- Stochastic Oscillator
- CLGN 3.64
- GLST 2.89
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About GLST Global Star Acquisition Inc.
Global Star Acquisition Inc is a blank check company.